ARCHIVES

The Cancer Letter Wins Investigative Reporting Award

This article is from The Cancer Letter archive.

Vol. 27 No. 23 | June 8, 2001

Download PDF Visit The Full Archive

Related Articles

NCI Hits Grant Targets, But Labs Feel The Pain Of Budget Cuts, Director Says.

November 23, 2007

Firm Begins Phase II Trial Of LDP-341 For Myeloma.

March 30, 2001

NCI Advisors Approve $20.5M Program Of Grants, Contracts For Biospecimen Research.

July 6, 2007

NSABP Executive Committee Joins Fisher In Suit Against Pitt

August 5, 1994

The Cancer Letter Wins Awards (12-page issue).

June 13, 2003

FDA Approves Velcade For Treatment Of Refractory Multiple Myeloma

May 30, 2003